SIGN UP
LOG IN
MARKET
SEEL
SEEL
Seelos Therapeutics Inc
NASDAQ
1.380
+0.120
+9.52%
After Hours: 1.380 0 0.00% 19:52 12/01 EST
OPEN
1.160
PREV CLOSE
1.260
HIGH
1.400
LOW
1.155
VOLUME
1.86M
TURNOVER
0
52 WEEK HIGH
49.80
52 WEEK LOW
0.1065
MARKET CAP
7.71M
P/E (TTM)
-0.1030
1D
5D
1M
3M
1Y
5Y
Seelos Therapeutics Inc: Current report
Press release · 1d ago
SEEL, AMPE and MOR among pre-market losers
Seel, ampe and mor among pre-market losers. Smart for life (smfl) announces exercise of warrants for $1.5 million. Dell technologies (dell) down 5% after q3 earnings release. Seel, minm, grom, mor, adtx, iccm, cdio, vvos and others in the red.
Seeking Alpha · 2d ago
Health Care Sector Update for 11/29/2023: SEEL, EGRX, VVOS, CI, HUM
NASDAQ · 3d ago
Seelos Therapeutics' $5.55M Public Offering As Stock Drop 35%
Benzinga · 3d ago
Dow Jumps Over 100 Points; Hormel Foods Earnings Miss Estimates
Dow jones index up 0.42% to 35,564.02; the nasdaq rises 0.17%. U.s. Stocks traded higher toward the end of trading on wednesday. Vivos therapeutics shares shot up 301% after receiving fda clearance for sleep apnea treatment. Hormel foods corp reported weaker-than-expected earnings for fourth quarter. Asian markets closed mostly lower; european shares closed mostly higher.
Benzinga · 3d ago
Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Patterson companies, inc. Shares fell 14% after the company reported worse-than-expected second-quarter results. Vivos therapeutics shares jumped 135.2% to $10.53 after receiving 510(k) clearance for sleep apnea treatment. China pharma holdings, inc., vivos and others were among the top gainers.
Benzinga · 3d ago
VTVT, HTOO and SOND among mid-day movers
Vtvt, htoo and sond among mid-day movers. Vivos therapeutics, vivos and proof are among the gainers. Biovie, farfetch and bmea among the losers in the biotechnology sector.
Seeking Alpha · 3d ago
Crude Oil Rises 1%; Rover Group Shares Spike Higher
U.s. Stocks traded higher on wednesday, with the dow jones index gaining more than 50 points. Vivos therapeutics shares shot up 215% after receiving fda clearance for new sleep apnea treatment. Eia says crude oil inventories increased by 1.609 million barrels in the week ending nov. 24. Asian markets closed lower; european shares were mostly higher.
Benzinga · 3d ago
About SEEL
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. The Company operates under one segment which develops pharmaceutical products. The Company's programs include SLS-002 for the potential treatment of acute suicidal ideation and behavior (ASIB) in patients with major depressive disorder (MDD) and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS) and spinocerebellar ataxia (SCA). SLS-002 is intranasal racemic ketamine with two investigational new drug applications (INDs). SLS-005 is used for the potential treatment of Sanfilippo Syndrome. SLS-005 is IV trehalose, a protein stabilizer that crosses the blood-brain barrier and activates autophagy and the lysosomal pathway. The Company's ongoing programs include SLS-004, SLS-006, and SLS-007.
Webull offers Seelos Therapeutics Inc stock information, including NASDAQ: SEEL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEEL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading SEEL stock methods without spending real money on the virtual paper trading platform.